Last SFr.92.35 CHF
Change Today -1.20 / -1.28%
Volume 4.1M
NOVN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Mexico
SIX Swiss Ex
Frankfurt
As of 11:43 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kim Stratton

Former Head of Group Country Management and External Affairs, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 142 board members in 1 different organizations across 5 different industries.

See Board Relationships
----

Background*

Ms. Kim Stratton serves as Head of International Commercial at Shire plc. Ms. Stratton served as Head of Group Country Management and External Affairs at Novartis AG and Novartis Vaccines and Diagnostics, Inc. since February 8, 2010. Ms. Stratton leads the Respiratory and Dermatology franchises for the U.S. business and help drive sales in the world's largest pharmaceutical market. Ms. Stratton served as Head of the Country Pharma Organization and Country President for ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.92.35 CHF -1.20

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$1.1M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.8M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Paul R. Perreault BA PsychologyChief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee
CSL Ltd.
$3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.